Accession Number: | 0001567619-22-013993 |
Date: | 2022-07-11 |
Issuer: | PLIANT THERAPEUTICS, INC. (PLRX) |
Original Submission Date: |
COULIE BERNARD
C/O PLIANT THERAPEUTICS, INC.
260 LITTLEFIELD AVENUE
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-07-11 | M | 15,000 | a | $2.08 | 74,273 | direct | ||
COMMON STOCK | 2022-07-11 | S | 15,000 | d | $22.50 | 59,273 | direct | ||
COMMON STOCK | 2022-07-12 | M | 12,498 | a | $2.08 | 71,771 | direct | ||
COMMON STOCK | 2022-07-12 | S | 12,498 | d | $22.50 | 59,273 | direct | ||
COMMON STOCK | 2022-07-11 | 0 | $0.00 | 449,317 | indirect | f3 |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 2.08 | 2022-07-11 | deemed execution date | M | 15,000 (d) | 2029-01-23 | common stock 15,000 | $2.08 | 322,380 | direct | ||
STOCK OPTION (RIGHT TO BUY) | 2.08 | 2022-07-12 | deemed execution date | M | 12,498 (d) | 2029-01-23 | common stock 12,498 | $2.08 | 309,882 | direct |
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on september 22, 2020. |
f2 | includes 4,433 shares of common stock acquired by the reporting person pursuant to an employee stock purchase program. |
f3 | shares held by the coulie/leyman family trust. the reporting person and his spouse serve as trustees for the trust. the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of section 16 or for any other purpose. |
f4 | 1/48th of the shares subject to the original option grant vest and become exercisable in substantially equal installments on each monthly anniversary of january 24, 2019, subject to the reporting person's continuous service to the issuer on each such date. |